Skip to main content
Clinical Trials/EUCTR2005-000877-23-GB
EUCTR2005-000877-23-GB
Active, not recruiting
Not Applicable

Is Remifentanil better than Propofol in providing optimal conditions for an awake fibreoptic intubation? - Remifentanil Vs Propofol for awake fibreoptic intubation

Oxford Radcliffe Hospitals NHS trust0 sites24 target enrollmentMarch 11, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Oxford Radcliffe Hospitals NHS trust
Enrollment
24
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2005
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Oxford Radcliffe Hospitals NHS trust

Eligibility Criteria

Inclusion Criteria

  • Patient inclusion Criteria:
  • \* ASA I\-III patients requiring awake fibre optic intubation.
  • \* ASA\- American society of Anesthesologist's classification of a patients physical status
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Patient exclusion Criteria:
  • Pregnant women
  • Allergy to drugs used
  • . Non English speaking
  • Unstable ward observations( acutely ill)
  • Inability to communicate effectively

Outcomes

Primary Outcomes

Not specified

Similar Trials